328 related articles for article (PubMed ID: 17049307)
1. Targeting dendritic cells with biomaterials: developing the next generation of vaccines.
Reddy ST; Swartz MA; Hubbell JA
Trends Immunol; 2006 Dec; 27(12):573-9. PubMed ID: 17049307
[TBL] [Abstract][Full Text] [Related]
2. Biomaterials as vaccine adjuvants.
Jones KS
Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
Klippstein R; Pozo D
Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
[TBL] [Abstract][Full Text] [Related]
4. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
[TBL] [Abstract][Full Text] [Related]
5. A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines.
Acharya AP; Clare-Salzler MJ; Keselowsky BG
Biomaterials; 2009 Sep; 30(25):4168-77. PubMed ID: 19477505
[TBL] [Abstract][Full Text] [Related]
6. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
[TBL] [Abstract][Full Text] [Related]
7. Targeting nanoparticles to dendritic cells for immunotherapy.
Cruz LJ; Tacken PJ; Rueda F; Domingo JC; Albericio F; Figdor CG
Methods Enzymol; 2012; 509():143-63. PubMed ID: 22568905
[TBL] [Abstract][Full Text] [Related]
8. Strategies for optimizing targeting and delivery of mucosal HIV vaccines.
Ahlers JD; Belyakov IM
Eur J Immunol; 2009 Oct; 39(10):2657-69. PubMed ID: 19609978
[TBL] [Abstract][Full Text] [Related]
9. Exploiting lymphatic transport and complement activation in nanoparticle vaccines.
Reddy ST; van der Vlies AJ; Simeoni E; Angeli V; Randolph GJ; O'Neil CP; Lee LK; Swartz MA; Hubbell JA
Nat Biotechnol; 2007 Oct; 25(10):1159-64. PubMed ID: 17873867
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
[TBL] [Abstract][Full Text] [Related]
11. Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives.
Akagi T; Wang X; Uto T; Baba M; Akashi M
Biomaterials; 2007 Aug; 28(23):3427-36. PubMed ID: 17482261
[TBL] [Abstract][Full Text] [Related]
12. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines.
Ahlers JD; Belyakov IM
Trends Mol Med; 2009 Jun; 15(6):263-74. PubMed ID: 19487159
[TBL] [Abstract][Full Text] [Related]
13. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
Wang X; Uto T; Akagi T; Akashi M; Baba M
J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
[TBL] [Abstract][Full Text] [Related]
14. Polymeric particles in vaccine delivery.
Rice-Ficht AC; Arenas-Gamboa AM; Kahl-McDonagh MM; Ficht TA
Curr Opin Microbiol; 2010 Feb; 13(1):106-12. PubMed ID: 20079678
[TBL] [Abstract][Full Text] [Related]
15. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
16. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
Tacken PJ; de Vries IJ; Torensma R; Figdor CG
Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-based cancer vaccination: quo vadis?
Dauer M; Schnurr M; Eigler A
Expert Rev Vaccines; 2008 Sep; 7(7):1041-53. PubMed ID: 18767953
[TBL] [Abstract][Full Text] [Related]
20. Cancer vaccines for established cancer: how to make them better?
Andrews DM; Maraskovsky E; Smyth MJ
Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
